Patents Examined by Ralph J. Gitomer
  • Patent number: 11000591
    Abstract: The present invention discloses a multifunctional traditional Chinese medicine health pillow. The health pillow is in an inverted concave shape; an outermost layer is a dense old coarse cloth sheet. The health pillow of the present invention not only treats cervical spondylosis, but also can activate blood circulation to dissipate blood stasis, reconcile yin and yang, regulate pulmonary function, regulate blood pressure and reduce blood lipid, treat insomnia, forgetfulness and neurasthenia, conduct effective hypnosis and sleep aid, and is more widely used in adjunctive therapy of cervical vertebra syndrome, scapulohumeral periarthritis, ankylosing spondylitis, lumbar muscle strain, lumbar vertebrae hyperplasia, lumbar disc herniation, sciatica, multiple peripheral neuritis, rheumatic fibrositis, atrophic lateral sclerosis, pain caused by bone degenerative change and pain caused by various soft tissue injuries.
    Type: Grant
    Filed: August 23, 2019
    Date of Patent: May 11, 2021
    Inventor: Jisheng Li
  • Patent number: 11000056
    Abstract: The present invention provides bioactive serum fractions and bioactive extracts derived from an Achachairu (Garcinia humilis) plant. The bioactive serum fractions and bioactive extracts are free of or substantially free of benzophenone and/or free of or substantially free of proteins. The present invention also provides products comprising the bioactive serum fractions and/or bioactive extracts. The present invention further provides methods of making the bioactive serum fractions and/or bioactive extracts.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: May 11, 2021
    Assignee: ISP Investments LLC
    Inventors: Olga Dueva-Koganov, Michael Koganov, Paul Recht, Artyom Duev, Li Zhang, Steven Micceri, Robert Turner
  • Patent number: 10993980
    Abstract: Present disclosure provides a pharmaceutical composition or a preparation composition containing fermented papaya preparation as an active ingredient for treating a patient with electrohypersensitivity or relieving a symptom thought to be a symptom of the electrohypersensitivity, and methods of use thereof.
    Type: Grant
    Filed: August 27, 2019
    Date of Patent: May 4, 2021
    Assignee: Osato International Inc.
    Inventors: Yukiyasu Hayashi, Dominique Belpomme
  • Patent number: 10993981
    Abstract: A composition for the treatment of follicular tonsillitis is provided. The composition includes a therapeutically effective amount of carnosic acid and a carrier consisting of pharmaceutically acceptable solvents and ingredients. The composition is in the form of spray and includes ethanol and polyoxyethylenesorbitan monooleate and at least 0.1% oregano essential oil. Other compositions and treatment methods are disclosed.
    Type: Grant
    Filed: July 10, 2017
    Date of Patent: May 4, 2021
    Assignee: THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIATION (ARO), (VOLCANI CENTER)
    Inventors: Yoseph Rakover, Nativ Dudai
  • Patent number: 10987386
    Abstract: The present invention relates to an extracellular vesicle derived from Lactobacillus paracasei and a use thereof, and more particularly, to a composition for alleviating, preventing or treating an inflammation disease and a cancer, which comprises an extracellular vesicle derived from Lactobacillus paracasei, which may effectively inhibit various inflammation disease, as an active ingredient, and the like.
    Type: Grant
    Filed: February 5, 2020
    Date of Patent: April 27, 2021
    Assignee: MD HEALTHCARE INC.
    Inventors: Yoon-Keun Kim, Chang Mo Moon
  • Patent number: 10980842
    Abstract: The present invention relates to a composition for improving bone health, and the composition includes a fermented extract extracted from a fermented material of oysters, which is obtained by fermenting oysters, and the fermented extract may promote bone formation by suppressing the activity of osteoclasts and promoting the activity of osteoblasts. The composition contains large amounts of taurine and vitamins, and natural gamma-aminobutyric acid.
    Type: Grant
    Filed: June 14, 2019
    Date of Patent: April 20, 2021
    Assignee: JEJU NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Gi-Young Kim, Yung Hyun Choi, Eui Kyun Park, Bae Jin Lee, You-Jin Jeon
  • Patent number: 10980735
    Abstract: The present invention relates to a skin external composition containing an extract of green tea produced by an extreme light-shielding cultivation method, which is distinguished from a conventional light-shielding cultivation method of green tea. More specifically, the present invention relates to a skin external composition, which contains an extract of green tea cultivated by extreme light-shielding, in which the amino acid content is remarkably increased by cultivating the green tea by a light-shielding cultivation under a light-shielding rate of 99% or more, thereby obtaining more excellent skin moisturizing, skin protecting, and anti-aging effects.
    Type: Grant
    Filed: September 21, 2017
    Date of Patent: April 20, 2021
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Yeong Ran Lee, Jun Seong Park, Eun Soo Lee, Nok Hyun Park
  • Patent number: 10967023
    Abstract: Disclosed is a Chinese medicinal composition prepared from the following medical raw materials in parts by weight: 1 part of ginseng, 0.8-1.5 parts of ginkgo leaf and 0.018-0.030 part of stigma croci.
    Type: Grant
    Filed: July 9, 2019
    Date of Patent: April 6, 2021
    Assignee: Shineway Pharmaceutical Group Ltd.
    Inventors: Jianxun Liu, Vivian Zhang, Zhigang Li, Shyflysky Zhang, Xiuwei Guan, Iris Lu, Weibo Gao, Li Xu, Wenting Song
  • Patent number: 10960027
    Abstract: The present disclosure provides compositions composed of amniotic fluid and/or modified amniotic fluid, a pharmaceutically acceptable carrier, and optionally a placental tissue graft, micronized placental tissue components, or extracts derived therefrom. Also described are systems and apparatuses for administering or storing said compositions, as well as methods of treatment using said compositions.
    Type: Grant
    Filed: March 23, 2017
    Date of Patent: March 30, 2021
    Assignee: MiMedx Group, Inc.
    Inventors: Thomas J. Koob, Michelle Massee
  • Patent number: 10953063
    Abstract: A multi time-phase treatment for one of a range of maladies. A dosage form is administered in a first dosage of a therapeutic effective amount of a first plant concentrate or one of its physiological acceptable forms. A dosage form is administered in a second dosage of a therapeutic effective amount of a second plant concentrate or one of its physiological acceptable forms. The first dosage is applied at a first time-phase and the second dosage is applied at a second time-phase spaced from the first time-phase. A combination of the first and second dosage forms administered in at least the first and second time-phases assist in treatment of abnormal cells for treatment for one of the range of maladies.
    Type: Grant
    Filed: February 27, 2019
    Date of Patent: March 23, 2021
    Inventors: Jenny Lee, Helen Chui Lan Chai
  • Patent number: 10945945
    Abstract: Stabilized skin care compositions are described. The compositions comprise a fish oil component that yields a product of oxidation and the component is stabilized with a radical scavenger, a peroxide decomposer and hydroxylated fatty acid and/or a derivative thereof.
    Type: Grant
    Filed: December 12, 2017
    Date of Patent: March 16, 2021
    Assignee: CONOPCO, INC.
    Inventors: Marina Tomashevskaia, Hasiba Bekto
  • Patent number: 10940187
    Abstract: Disclosed in this application are compositions which include digestive enzymes and which are formulated to reduce one or more symptoms of Schizophrenia or a Schizophreniform Disorder. Also disclosed is a method for treating an individual with Schizophrenia or a Schizophreniform Disorder using digestive enzymes and their derivatives to alleviate the symptoms of Schizophrenia or a Schizophreniform Disorder. The method comprises administering to the individual an effective amount of digestive enzymes that are either naturally or recombinantly derived, or their derivatives, in an amount effective to reduce one or more symptoms of Schizophrenia or a Schizophreniform Disorder.
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: March 9, 2021
    Assignee: CUREMARK, LLC
    Inventors: Joan M. Fallon, Matthew Heil, James Szigethy, James Fallon
  • Patent number: 10940130
    Abstract: An anxiolytic composition includes a synergistic combination of an L-theanine and a whey protein composition.
    Type: Grant
    Filed: June 11, 2019
    Date of Patent: March 9, 2021
    Assignee: NUTRAMAX LABORATORIES, INC.
    Inventors: Todd Henderson, David Griffin, David Bledsoe
  • Patent number: 10940168
    Abstract: A composition includes a sea cucumber and ginseng/red ginseng composite extract which has the effect of regenerating the Bruch's membrane of the eye and improving the transport function of the Bruch's membrane. The composite composition improves the transport function of the Bruch's membrane and eliminates lipids accumulated on the membrane to promote the regeneration of the Bruch's membrane, thereby showing the effect of delaying or reversing the senescence process of the eye. Further, the composition is highly preventive or therapeutic of various diseases attributed to a decrease in the function of the Bruch's membrane with age, including age-related macular degeneration (AMD) and can solve the problem associated with the eye health maintenance of ordinary persons and with the transport reduction, resulting from senescence, of vitamins, metals, and anti-oxidative materials.
    Type: Grant
    Filed: February 8, 2018
    Date of Patent: March 9, 2021
    Assignee: ALTREGEN CO., LTD.
    Inventors: Yunhee Lee, Ali Hussain, Dae Bong Kim
  • Patent number: 10925917
    Abstract: The present invention describes extracts of Polygonum cuspidatum and related compositions that are capable of photodynamic inactivation (PDI) of microorganisms such as bacteria, viruses, fungi, and protozoa, and capable of killing or inactivating cancer cells. The present invention further describes methods of using said Polygonum cuspidatum extracts and photodynamic inactivation (PDI) as a therapy for the treatment of microbial infection and as well as the use of Polygonum cuspidatum extract and related compositions as photodynamic therapy agents for the treatment of cancer.
    Type: Grant
    Filed: February 1, 2019
    Date of Patent: February 23, 2021
    Assignee: PhotoDynamic Inc.
    Inventor: Sherri McFarland
  • Patent number: 10925304
    Abstract: The present invention can provide: a prophylactic or ameliorating/therapeutic agent for chronic fatigue syndrome, idiopathic chronic fatigue and fibromyalgia, which contains a processed product of Japanese horseradish (wasabi) as an active ingredient; a food, a beverage, a medicine or a cosmetic, and a medicine for preventing or ameliorating/treating diseases relating to chronic fatigue syndrome, idiopathic chronic fatigue and fibromyalgia, each of which contains the processed product of wasabi; and methods for using these products.
    Type: Grant
    Filed: December 28, 2017
    Date of Patent: February 23, 2021
    Assignee: PRODUCTIVE AGING LABORATORY, CO., LTD.
    Inventors: Yasuhito Nakatomi, Yosky Kataoka, Yo-ichi Nabeshima
  • Patent number: 10925914
    Abstract: The present invention provides a health functional food composition and a pharmaceutical composition for preventing and alleviating depression, both compositions using an extract of Vaccinium bracteatum Thunb. fruits, which are Korean natural resources, so as to be safely usable without toxicity and side effects.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: February 23, 2021
    Assignee: JEONNAM BIOINDUSTRY FOUNDATION
    Inventors: Chul Yung Choi, Jae Yong Kim, Gyu Ok Lee, Ja Won Shin, Hu Won Kang, Ara Jo, Hak Joon Choi, Sang O Pan, Sung Yoon Park, Hyo Jeong Yun, So Jeong Im, Mi Ri Kim, Yong Uk Kim, Dool-Ri Oh, Eun Jin Choi, Yu Jin Kim, Dong Hyuck Bae, KyoNyeo Oh, Myung-A Jung, Ji Ae Hong, Hyun Mi Lee, Rack Seon Seong
  • Patent number: 10925912
    Abstract: The invention discloses a ginseng-derived nanoparticle and a preparation method and application thereof. The ginseng-derived nanoparticle disclosed in the invention has a membrane structure, a particle size ranging from 150 to 500 nm and a peak particle size of 280 to 350 nm; and the ginseng-derived nanoparticle is prepared by multiple centrifugation, filtration and impurity removal. The ginseng-derived nanoparticle has good application prospects in developing drugs for preparing natural immunopotentiators and for preparing natural anti-tumor drugs.
    Type: Grant
    Filed: June 19, 2017
    Date of Patent: February 23, 2021
    Assignee: JIANGSU PROVINCE INSTITUTE OF TRADITIONAL CHINESE MEDICINE
    Inventors: Peng Cao, Meng Cao, Huaijiang Yan
  • Patent number: 10918674
    Abstract: The present invention relates to a method for preparing a bird's nest extract and the various extracts obtained from said method. In an aspect of the present invention, there is provided a method for preparing a bird's nest extract, the extract comprising at least one molecule obtained from edible bird's nest (EBN), the method comprising the steps of: (a) washing raw EBN; (b) filtering the washed EBN; (c) extracting the molecule from the EBN; and (d) isolating the molecule.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: February 16, 2021
    Inventor: Kah Meng Lim
  • Patent number: 10912864
    Abstract: Compositions including a first soft tissue-derived matrix and a second soft tissue-derived matrix are provided, as well as methods of making such compositions. In some embodiments, the composition comprises delipidated, decellularized adipose tissue-derived matrix and delipidated, decellularized fascial tissue-derived matrix, which may be combined in various proportions. Such adipose-fascia matrix compositions provide improved volume retention when implanted into a patient. The composition may further include exogenous cells or other substances, and/or a carrier. The composition is suitable for use inplastic surgery procedures, including reconstructive or cosmetic surgery procedures, as well as procedures for wound treatment and tissue regeneration.
    Type: Grant
    Filed: May 31, 2019
    Date of Patent: February 9, 2021
    Assignee: Musculoskeletal Transplant Foundation
    Inventors: Benjamin Schilling, Andrew Madans, Abigail Phipps, Thomas Tylutki, Todd Nilsen, Yen-Chen Huang, Evangelia Chnari